COVID-19 is impacting all of us and challenging previous ways of working. This is a period of disruption.

However, we can embrace this new reality with confidence and adapt the way we work, the way we strategize, and the way we generate, use, and disseminate real world evidence (RWE) to better inform decision making. Stakeholders across the healthcare ecosystem (regulators, payers, providers, and patients) are adopting new solutions enabled by technology to navigate this era of change.

In this new reality, RWE will take a more prominent role to improve patient outcomes, meet stakeholder needs, and answer business questions.

Join Pharmaceutical Executive®, IQVIA, and leading healthcare industry thought leaders to better understand the role and importance of RWE during and after COVID-19, what it means for your business today, and how you can plan for tomorrow with confidence.

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.